Class 005: Pharmaceuticals, namely, plasma derived and recombinant immunoglobulins for use in the treatment of infectious diseases, namely, CMV disease, Hepatitis B, Varicella Zoster, and rabies, Hematologic conditions including Idiopathic Thrombocytopenic Purpura; Respiratory conditions including Alpha-1 Antitrypsin Deficiency, Obstetrics and Gynecology conditions such as hemolytic disease of the newborn, Transplantation treatments including solid-organ transplants and hematopoietic stem-cell transplantation; pharmaceuticals namely plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders and treating inflammatory diseases; pharmaceuticals namely coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thromboembolic disorders; pharmaceutical preparations for anesthesia analgesia for surgery; pharmaceutical preparations for treatment of CMV infection and disease; pharmaceutical preparations for the treatment of Varicella Zoster Virus; pharmaceutical preparations for treatment of Hepatitis; pharmaceutical preparations for the treatment of Rabies
